2E "Patient Safety and Drug Review Transparency Act"; requiring disclosure of clinical trials for prescription drugs by manufacturers; specifying certain information disclosure and application requirements; requiring posting of clinical trail information on an accessible internet web site; defining certain terms; assessing fees; specifying certain compliance dates
(me)